Arroyo-Villa et al. reported reduced levels of both IL-17 and Th17 cells in early RA patients [52], while Fazaa et al. failed to observe any differences in the Th17 cell percentage and IL-17 concentration between patients and controls [59]. This evidence concerns the gene IL17A and rheumatoid arthritis.